HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Systolic Hypertension in the Elderly Program (SHEP): antihypertensive efficacy of chlorthalidone.

Abstract
The Systolic Hypertension in the Elderly Program (SHEP) is a randomized, blinded test of the efficacy of antihypertensive drug treatment. In a large feasibility trial, 551 men and women who had isolated systolic hypertension and were at least 60 years old received chlorthalidone (25 to 50 mg/day) or matching placebo as the step I drug. After 1 year, 83% of the chlorthalidone group and 80% of the placebo group were still taking SHEP medications. Of those still taking chlorthalidone, 88% had reached goal blood pressure (BP) without requiring a step II drug, and most had responded to the lower dose (25 mg/day). The BP response was similar in all age, sex and race subgroups, with an overall mean difference between randomized groups of 17 mm Hg for systolic BP (p less than 0.001) and 6 mm Hg for diastolic BP (p less than 0.001). The only common adverse effects were asymptomatic changes in the serum levels of potassium (0.5 mEq/liter lower in the chlorthalidone group, p less than 0.001), uric acid (0.9 mg/dl higher, p less than 0.001) and creatinine (0.08 mg/dl higher, p = 0.02). This study indicates that chlorthalidone is effective for lowering BP in elderly patients with systolic hypertension and sets the stage for a larger trial of the effects of such treatment on the incidence of cardiovascular disease.
AuthorsS B Hulley, C D Furberg, B Gurland, R McDonald, H M Perry, H W Schnaper, J A Schoenberger, W M Smith, T M Vogt
JournalThe American journal of cardiology (Am J Cardiol) Vol. 56 Issue 15 Pg. 913-20 (Dec 01 1985) ISSN: 0002-9149 [Print] United States
PMID4072925 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Creatinine
  • Chlorthalidone
  • Potassium
Topics
  • Aged
  • Blood Pressure (drug effects)
  • Chlorthalidone (therapeutic use)
  • Creatinine (blood)
  • Double-Blind Method
  • Feasibility Studies
  • Female
  • Humans
  • Hypertension (drug therapy)
  • Male
  • Middle Aged
  • Patient Compliance
  • Potassium (blood)
  • Random Allocation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: